Thompson Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-89,784
Closed -$8.92M 196
2019
Q3
$8.92M Sell
89,784
-10
-0% -$950 1.74% 11
2019
Q2
$8.3M Sell
89,794
-4,432
-5% -$421K 1.62% 14
2019
Q1
$8.89M Buy
94,226
+865
+0.9% +$75.7K 1.7% 11
2018
Q4
$5.98M Sell
93,361
-2,817
-3% -$208K 1.4% 17
2018
Q3
$8.61M Buy
96,178
+11,100
+13% +$981K 1.53% 16
2018
Q2
$6.76M Buy
85,078
+22,685
+36% +$1.88M 1.23% 24
2018
Q1
$5.57M Buy
62,393
+6,278
+11% +$603K 1.04% 30
2017
Q4
$5.86M Buy
56,115
+6,445
+13% +$727K 1.03% 32
2017
Q3
$7.24M Sell
49,670
-571
-1% -$77.8K 1.35% 20
2017
Q2
$6.53M Sell
50,241
-840
-2% -$103K 1.23% 22
2017
Q1
$6.36M Buy
51,081
+1,556
+3% +$186K 1.21% 23
2016
Q4
$5.73M Sell
49,525
-2,608
-5% -$290K 1.12% 24
2016
Q3
$5.45M Sell
52,133
-80
-0.2% -$8.66K 1.05% 27
2016
Q2
$5.15M Buy
52,213
+2,289
+5% +$237K 1.05% 29
2016
Q1
$5M Buy
49,924
+2,260
+5% +$233K 1.04% 31
2015
Q4
$5.71M Buy
47,664
+790
+2% +$91.4K 1.19% 21
2015
Q3
$5.07M Sell
46,874
-3,217
-6% -$399K 1.09% 27
2015
Q2
$5.8M Buy
50,091
+874
+2% +$99.9K 1.11% 31
2015
Q1
$5.67M Sell
49,217
-1,329
-3% -$159K 1.08% 30
2014
Q4
$5.65M Sell
50,546
-2,830
-5% -$298K 1.08% 29
2014
Q3
$5.72M Sell
53,376
-1,840
-3% -$166K 1.09% 27
2014
Q2
$4.74M Buy
55,216
+1,900
+4% +$144K 0.92% 39
2014
Q1
$3.72M Sell
53,316
-110
-0.2% -$8.71K 0.74% 67
2013
Q4
$4.51M Sell
53,426
-2,100
-4% -$166K 0.89% 45
2013
Q3
$4.28M Sell
55,526
-290
-0.5% -$20.3K 0.92% 41
2013
Q2
$3.27M Buy
+55,816
New +$3.36M 0.75% 63

Other funds holding CELG

Thompson Investment Management's CELG Position: Q4 2019 in Review

Thompson Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 89,784 shares — an estimated $8.92M sold.

Thompson Investment Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $8.92M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Thompson Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Thompson Investment Management sold 89,784 Celgene Corp shares in Q4 2019, an estimated $8.92M.
  • Thompson Investment Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Thompson Investment Management's Celgene Corp position peaked at $8.92M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Thompson Investment Management's 13F filing for Q4 2019, filed 6 Feb 2020.